What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?

doi:10.4292/wjgpt.v7.i3.387

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8301)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

559

WORD

383

HTML

4108

Tables (1-2)

567

Sum=5617

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1063

Download

1621

Sum=2684

Aug 6, 2016 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Pharmacol Ther. Aug 6, 2016; 7(3): 387-396
Published online Aug 6, 2016. doi: 10.4292/wjgpt.v7.i3.387

Table 2 Vaccination of inflammatory bowel disease patients on immunosuppressive therapy

Vaccine	Dose	Safety
Inactivated vaccines
HAV	2 doses	Yes
HBV	3 doses	Yes
HAV and HBV	3 doses	Yes
HPV	3 doses	Yes
Influenza (trivalent)	Annually	Yes
Meningococcal	≥ 1 dose	Yes
Pneumococcal	1 dose and 1 booster in 5 yr	yes
Tetanus and diphtheria	Every 10 yr	Yes
Live attenuated vaccines
BCG	1 dose	Contraindicated
MMR	1 or 2 doses	Contraindicated
Varicella	2 doses	Contraindicated
Zoster	1 doses	Contraindicated

HAV: Hepatitis A virus; HBV: Hepatitis B virus; HPV: Human papillomavirus; BCG: Bacillus Calmette Guérin; MMR: Measles, mumps, and rubella.

Citation: Andrisani G, Armuzzi A, Marzo M, Felice C, Pugliese D, Papa A, Guidi L. What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients? World J Gastrointest Pharmacol Ther 2016; 7(3): 387-396
URL: https://www.wjgnet.com/2150-5349/full/v7/i3/387.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v7.i3.387